Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Centre, Multi-National, Observational Post-Authorisation Safety Study to Document the Drug Utilisation of Samsca and to Collect Information on the Safety of Samsca When Used in Routine Medical Practice

NCT01228682 is registered in ClinicalTrials.gov with Otsuka Frankfurt Research Institute GmbH as lead sponsor.

NCT NCT01228682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01228682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Centre, Multi-National, Observational Post-Authorisation Safety Study to Document the Drug Utilisation of Samsca and to Collect Information on the Safety of Samsca When Used in Routine Medical Practice
Lead sponsor
Otsuka Frankfurt Research Institute GmbH
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2010
Completion date
April 30, 2014
Enrollment
200 (estimated)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

non-hyponatremia, non-siadh hyponatremia, siadh